Boulder Diagnostics
Boulder Diagnostics develops and markets cutting edge in vitro diagnostics for difficult to diagnose diseases such as Lyme and Q-fever.
- Stage Full Product Ready
- Industry Biotechnology
- Location Boulder, CO, USA
- Currency USD
- Founded July 2009
- Employees 11
- Website BoulderDiagnostics.com
Company Summary
Boulder Diagnostics Inc. is dedicated to bringing new diagnostic tests to market for diseases that are not reliably diagnosed today. We work with leading academic institutions and innovative companies to identify scientific breakthroughs that can deliver new, reliable diagnostic tests where today’s standard methods fail.
Team
-
Wolfgang PiekenChief Executive Officer
2009 - Present: CEO Boulder Diagnostics Inc
2007 - Present: Partner Inveni Capital
2003 - 2007: Partner Ventac Partners:
- Management Consultant HAC Biomed
2002 - 2005: CEO MWG Biotech AG
1998 - 2002: CEO Proligo LLC
1992 - 1998: NeXstar Pharmaceuticals
1990 - 1992: Max-Planck Institute for Experimental Medicine
1985 - 1989: Graduate School U Maryland -
Dede WillisChief Operating Officer
2009 - Present: COO Boulder Diagnostics
2003- Present: Partner, Ventac Partners
2004-2007: Vice President Operations, Colorado Altitude Training
1999-2002: VP Operations Proligo LLC and Managing Director, Proligo Biochemie GmbH
1998-1999 President & CEO, Herberts Refinishes Corp
1997-1998 Director, Strategy Development, Herberts GmbH
1984-1996: Hoechst Group
1992: University of Houston, MBA
1984: Clemson University, BS, Chemical Enginee
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.